75
Participants
Start Date
May 31, 2016
Primary Completion Date
May 31, 2020
Study Completion Date
May 31, 2020
Xen Matrix AB
Xen Matrix™ AB Surgical Graft is an acellular, sterile, non-pyrogenic porcine dermal matrix packed dry for use in the reconstruction of soft tissue deficiencies. The device surfaces are coated with the antibacterial agents Rifampin and Minocycline in a bioresorbable L-Tyrosine succinate polymer carrier.
Trustees of the University of Pennsylvania, Philadelphia
Duke University Medical Center, Durham
Emory University, Atlanta
Ohio State University, Columbus
Washington University, St Louis
Texas Tech University Health Sciences Center, El Paso
Keck Hospital of USC, Los Angeles
California Pacific Medical Center - Sutter Health, San Francisco
Oregon Health & Science University, Portland
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Lead Sponsor
C. R. Bard
INDUSTRY